Astra ends production of asthma inhaler – Newsday (subscription)

Astra ends production of asthma inhaler
Newsday (subscription)
By AP (AP) — AstraZeneca PLC is ending production of one version of its asthma drug Pulmicort immediately because of technical problems in manufacturing. Astra's announcement on Monday sent shares in its technology partner for the drug, SkyePharma,
SkyePharma Shares Fall As AstraZeneca Drops Asthma ProductWall Street Journal
SkyePharma crashesThis is London
AZ discontinues inhaler on 'technical issues'FiercePharma

all 54 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.